The high capital requirements and technical complexity of biological drug development are driving strategic collaborations across the biopharmaceutical sector. Strategic perspectives from the Biosimilars Market overview highlight how large pharmaceutical companies are forming joint ventures and licensing agreements with specialized biotechnology firms to share development risks and technical...
About
Terms
Privacy
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek